Sather Financial Group’s CVS Health CVS Stock Holding History

Sather Financial Group’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-3,500	Closed	-$279K	–	87
2024 Q1	$279K	Hold	3,500	–	–	0.02%	80
2023 Q4	$276K	Hold	3,500	–	–	0.02%	77
2023 Q3	$244K	Hold	3,500	–	–	0.02%	84
2023 Q2	$242K	Hold	3,500	–	–	0.02%	86
2023 Q1	$260K	Sell	3,500 -259	-7%	-$21.7K	0.02%	83
2022 Q4	$350K	Sell	3,759 -259	-6%	-$25K	0.03%	86
2022 Q3	$383K	Sell	4,018 -384	-9%	-$38K	0.04%	55
2022 Q2	$408K	Buy	4,402 +362	+9%	+$35.3K	0.04%	56
2022 Q1	$409K	Buy	4,040 +518	+15%	+$54.4K	0.04%	61
2021 Q4	$363K	Hold	3,522	–	–	0.03%	54
2021 Q3	$299K	Buy	+3,522	New	+$295K	0.03%	65
2018 Q3	–	Sell	-9,990	Closed	-$643K	–	61
2018 Q2	$643K	Hold	9,990	–	–	0.14%	46
2018 Q1	$621K	Buy	+9,990	New	+$717K	0.15%	45

Other funds holding CVS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Sather Financial Group's CVS Position: Q2 2024 in Review

Sather Financial Group sold out of CVS Health (CVS) in Q2 2024, closing a stake of 3,500 shares — an estimated $279K sold.

Sather Financial Group first reported a position in CVS in Q1 2018 and held it in 13 quarters. The position peaked at $643K in Q2 2018. 1,910 funds tracked by Wall St. Rank hold CVS as of Q2 2024.

Sather Financial Group reported no remaining CVS Health position as of Q2 2024 after selling out during the quarter.
Sather Financial Group sold 3,500 CVS Health shares in Q2 2024, an estimated $279K.
Sather Financial Group first reported a position in CVS Health in Q1 2018 and held it in 13 quarters.
Sather Financial Group's CVS Health position peaked at $643K in Q2 2018.
1,910 funds tracked by Wall St. Rank held CVS Health as of Q2 2024.

Based on Sather Financial Group's 13F filing for Q2 2024, filed 24 Jul 2024.